Filing Details

Accession Number:
0001209191-22-023666
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-07 16:19:29
Reporting Period:
2022-04-05
Accepted Time:
2022-04-07 16:19:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1679082 Myovant Sciences Ltd. MYOV Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1712069 Matthew Lang C/O Myovant Sciences Inc.
2000 Sierra Point Parkway, 9Th Floor
Brisbane CA 94005
General Counsel & Corp. Secy. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2022-04-05 2,436 $13.78 172,928 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
  2. The shares were sold at prices ranging from $13.78 to $13.86. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.